These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. Expansions of T-cell subsets expressing particular T-cell receptor variable regions in chronic beryllium disease. Fontenot AP; Kotzin BL; Comment CE; Newman LS Am J Respir Cell Mol Biol; 1998 Apr; 18(4):581-9. PubMed ID: 9533947 [TBL] [Abstract][Full Text] [Related]
15. Deficient and dysfunctional regulatory T cells in the lungs of chronic beryllium disease subjects. Mack DG; Lanham AM; Falta MT; Palmer BE; Maier LA; Fontenot AP Am J Respir Crit Care Med; 2010 Jun; 181(11):1241-9. PubMed ID: 20299529 [TBL] [Abstract][Full Text] [Related]
16. Beryllium induces IL-2 and IFN-gamma in berylliosis. Tinkle SS; Kittle LA; Schumacher BA; Newman LS J Immunol; 1997 Jan; 158(1):518-26. PubMed ID: 8977230 [TBL] [Abstract][Full Text] [Related]
17. HLA-DP-unrestricted TNF-alpha release in beryllium-stimulated peripheral blood mononuclear cells. Amicosante M; Berretta F; Franchi A; Rogliani P; Dotti C; Losi M; Dweik R; Saltini C Eur Respir J; 2002 Nov; 20(5):1174-8. PubMed ID: 12449171 [TBL] [Abstract][Full Text] [Related]
18. Cytokine production by bronchoalveolar lavage cells in chronic beryllium disease. Tinkle SS; Schwitters PW; Newman LS Environ Health Perspect; 1996 Oct; 104 Suppl 5(Suppl 5):969-71. PubMed ID: 8933043 [TBL] [Abstract][Full Text] [Related]
19. Target organ localization of memory CD4(+) T cells in patients with chronic beryllium disease. Fontenot AP; Canavera SJ; Gharavi L; Newman LS; Kotzin BL J Clin Invest; 2002 Nov; 110(10):1473-82. PubMed ID: 12438445 [TBL] [Abstract][Full Text] [Related]
20. 5-Aminosalicylic Acid Modulates the Immune Response in Chronic Beryllium Disease Subjects. Day BJ; Huang J; Barkes BQ; Gillespie M; Li L; Maier LA Lung; 2018 Feb; 196(1):103-114. PubMed ID: 29080069 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]